XML 51 R39.htm IDEA: XBRL DOCUMENT v3.26.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Reporting [Abstract]  
Schedule of Disaggregated Expenses
The following tables present disaggregated expenses that are regularly provided to the CODM:
Three Months Ended March 31,
20262025
Personnel compensation and related costs18,470 24,079 
Licensing fees22,000 19,997 
CROs/CMOs/Investigators expenses19,540 9,830 
Other costs5,581 6,823 
Total research and development expenses65,591 60,729 
Three Months Ended March 31,
20262025
Clinical programs31,090 28,092 
Pre-Clinical programs11,716 3,314 
Unallocated research and development expenses22,785 29,323 
Total research and development expenses65,591 60,729 

Three Months Ended March 31,
20262025
Personnel compensation and related costs41,060 40,643 
Other costs24,010 22,779 
Total selling, general, and administrative expenses65,070 63,422 
Three Months Ended March 31,
20262025
Selling and marketing expenses43,438 41,939 
General and administrative expenses21,632 21,483 
Total selling, general, and administrative expenses65,070 63,422